期刊文献+

老年冠心病患者介入治疗术后对比剂肾损伤发生率及危险因素分析 被引量:16

Incidence of and risk factors for contrast-induced nephropathy after percutaneous coronary intervention in elderly patients
下载PDF
导出
摘要 目的探讨老年冠心病患者PCI术后对比剂肾损伤(contrast-induced nephropathy,CIN)发生情况及危险因素。方法选取行PCI的老年冠心病患者945例,按照CIN诊断标准分为CIN组150例和非CIN组795例,比较2组相关因素的差异,应用多元logistic回归分析探讨CIN危险因素。结果 945例老年患者中,150例发生CIN,CIN发生率为15.9%。2组患者年龄、心肌梗死、糖尿病、低血压、红细胞计数、血红蛋白、贫血、LVEF、术前肾小球滤过率(GFR)、对比剂剂量等比较,差异有统计学意义(P<0.01)。多元logistic回归分析,心肌梗死、糖尿病、贫血、低血压、LVEF≤45%、GFR≤60 ml/(min·1.73 m^2)、急诊PCI、对比剂剂量>200 ml是老年冠心病患者CIN的危险因素(P<0.05,P<0.01)。结论 CIN是老年冠心病患者PCI术后一种不容忽视的并发症,患者行PCI时,应引起临床医师的格外重视。 Objctive To invetigate the incidence of contrast-induced nephropathy(CIN)and identify the risk factors for CIN after PCI in elderly patients. Methods A retrospective study was conduc- ted in Tianjin Chest Hospital on 945 elderly coronary heart disease patients received PCI from jan- ery 2009 to december 2010. Acorrding to the CIN criteria, the elderly patients were divided into CIN group and non-CIN group, and logistic regression analysis was applied to determin the risk factors for CIN. Results Among the 945 elderly patients,CIN occurred in 150 patients and the in- cidence of CIN was 15.9 %. There were statistically significant differences in age, hemoglobin, red blood cells, hematocrit,anemia, systolic blood pressure, LVEF and contrast agent volume between the two groups(P〈0.01), logistic regression analysis showed that myocardial infarction,diabetes mellitus,anemia,hypotention,LVEF≤45% ,GFR≤60 ml/(min·1.73 m2 ), urgent PCI, contrast agent volume〉200 ml were risk factors of CIN(P〈0. 05,P〈0.01). Conclusion CIN is a common complication after PCI in elderly patients, more attention should be paid to elderly patients with risk factors of CIN.
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2012年第2期154-157,共4页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
基金 天津市卫生局攻关项目(10KG122)
关键词 冠心病 肾病 造影剂 危险因素 coronary disease nephrosis contrast media risk factors
  • 相关文献

参考文献12

  • 1Chronopoulos A, Rosner MH, Cruz DN, et al. Acute kidney injury in the elderl a review. Contrib Nephrol, 2010, 165: 315 321.
  • 2李法琪,司良毅.老年医学.北京:科学出版社,2002.217-218.
  • 3Shepherd J, Kastelein JJ, Bittne V, et al. Effect of Intensive Lipid Lowering with Atorvastatin on Renal Function in Pa tients with Coronary Heart Disease: The Treating to New Targets(TNT). Clin J Am Soc Nephrol,2007,2:l131-1139.
  • 4刘润梅,夏云蜂,殷亚昕,翟红霞,李良.非离子造影剂对老年冠状动脉造影患者肾功能的影响[J].中华老年心脑血管病杂志,2006,8(3):180-183. 被引量:3
  • 5Cronin RE. Contrast-induced nephropathy: pathogenesis and prevention. Pediat r Nephrol, 2010,25 : 191-204.
  • 6Rosenstock JL,Gilles E,Geller AB,et al. Impact of heart fail- ure on the incidence of contrast-induced nephropathy in pa- tients with chronic kidney disease. Int Urol Nephrol, 2010, 42 : 1049-1054.
  • 7Nikolsky E, Mehran R, Lasic Z, et al. Low hematocrit predicts contrast induced nephropathy after percutaneous coronary in- terventions. Kidney Int, 2005,67 :706 -713.
  • 8Mautone A, Brown JR. Contrast-induced nephropathy in pa tients undergoing elective and urgent procedures. J Interv Cardiol, 2010,23 : 78-85.
  • 9Toso A, Leoncini M, Maioli M, et al. Short-term high-dose atorvastatin for periprocedural myocardial infarction preven tion in patients with renal dysfunction. J Cardiovasc Med, 2011,12:318-321.
  • 10Jo SH,Youn TJ,Koo BK,et al. Renal toxicity evaluation and comparison between visipaque(iodixanol) and hexabrix(ioxa glare) in patients with renal insufficiency undergoing coronar- yagiography: the RECOVER study: a randomized controlled trial. J Am Coil Cardiol, 2006,48 : 924-930.

二级参考文献9

  • 1Trivedi HS, Moore H, Nasr S, et al. A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity[ J]. Nephron Clin Pract,2003,93 : C29-C34.
  • 2Briguori C, Tavano D, Colobo A. Contrast agent-associated nephrotoxicity [ J ]. Prog Cardiovasc Dis, 2003,45 : 493-503.
  • 3Rihal CS,Textor SC, Grill DE, et al . Incidence and prognosis of acute renal failure after percutaneous coronary intervention [ J ]. Circulation,2002,105 : 2259-2264.
  • 4Shyu KG, Cheug J J, Kuan P. Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure[J]. J Am Coll Cardiol, 2002,40 : 1383-1388,
  • 5Morcos SK,Thomsen HS, Webb JA. Contrast-media induced nephrotoxicity: a consensus report Contrast Media Safety Committee, European Society of Urogenital Radiology(ESUR) [ J ]. Eur radiol, 1999,9:1602-1613.
  • 6Wang A, Holoslaw T, Bashore TM, et al. Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism[ J ]. Kidney Int, 2000,57 : 1675-1680.
  • 7Thompson EJ, king SL. Acetylcysteine and fenoldopam. Promising new approaches for preventing effects of contrast nephrotoxicity [J]. Crit care Nurse, 2003,23 : 39-46.
  • 8龚志华,向定成.非离子型造影剂对肾功能正常和肾功能不全患者肾功能的影响[J].临床心血管病杂志,2003,19(4):243-244. 被引量:10
  • 9张永强,颜光烈.碘普罗胺冠状动脉造影对冠心病患者肾功能的影响[J].心血管康复医学杂志,2004,13(2):141-143. 被引量:4

共引文献3

同被引文献116

引证文献16

二级引证文献122

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部